Company profile for Kato Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kato Pharmaceuticals is a clinical stage Bio-pharmaceutical company dedicated to the development of therapies for pathologies of the eye with an emphasis on unmet medical needs. Kato is a clinical stage Biopharmaceutical company dedicated to the development of novel therapies for pathologies of the eye with an emphasis on unmet medical needs. Founded in 2012 and located in Laguna Hills, California, Kato Pharmaceuticals, is ...
Kato Pharmaceuticals is a clinical stage Bio-pharmaceutical company dedicated to the development of therapies for pathologies of the eye with an emphasis on unmet medical needs. Kato is a clinical stage Biopharmaceutical company dedicated to the development of novel therapies for pathologies of the eye with an emphasis on unmet medical needs. Founded in 2012 and located in Laguna Hills, California, Kato Pharmaceuticals, is a privately held company portfolio company. Kato is a clinical stage biopharmaceutical company dedicated to the development of novel therapies for diseases of the eye, including di

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
26051 Merit Circle, Suite 102 Laguna Hills, CA 92653
Telephone
Telephone
(949) 348-1188
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.pharmabiz.com/NewsDetails.aspx?aid=145903&sid=2

PHARMABIZ
18 Feb 2022

https://www.prnewswire.com/news-releases/kato-wins-fda-approval-for-human-studies-of-drug-for-retinal-disorders-301484401.html

PRNEWSWIRE
16 Feb 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty